Researcher.Life Logo

JBMR Plus : Impact Factor & More

eISSN: 2473-4039pISSN: 2473-4039
JournalOpen Access

Key Metrics

CiteScore
5
SJR
Q3Orthopedics and Sports Medicine
SNIP
1.32
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JBMR Plus

JBMR Plus Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesUSD 2500
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorAmerican Society for Bone and Mineral Research
FrequencyMonthly
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in JBMR Plus ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JBMR Plus

Comprehensive profiling of the competitive interplay among carbamylation, glycation, and enzymatic cross-links in human bone.
  • 1 Jun 2026
  • JBMR plus
Opportunities for deep learning techniques to advance the histological analysis of preclinical models of osteoarthritis beyond ordinal rank systems.
  • 1 Jun 2026
  • JBMR plus
Efficacy, pharmacodynamics, pharmacokinetics, safety, and immunogenicity of Bmab 1000 vs reference denosumab: 78-wk results from a randomized, double-blind, multicenter, parallel-arm Phase 3 trial (DEVOTE) in women with postmenopausal osteoporosis.
  • 1 Jun 2026
  • JBMR plus
Evaluation of the use of segmentation-based and deconvolution-based three-dimensional joint space width analysis of the hand and wrist.
  • 1 Jun 2026
  • JBMR plus
An osteoporotic bone model: developing and validating an ex-vivo bone demineralization protocol.
  • 1 Jun 2026
  • JBMR plus
Risk factors for atypical femur fractures with and without bisphosphonate treatment: a national nested case-control study.
  • 1 Jun 2026
  • JBMR plus
Comprehensive profiling of the competitive interplay among carbamylation, glycation, and enzymatic cross-links in human bone.
  • 1 Jun 2026
  • JBMR plus
Opportunities for deep learning techniques to advance the histological analysis of preclinical models of osteoarthritis beyond ordinal rank systems.
  • 1 Jun 2026
  • JBMR plus
Efficacy, pharmacodynamics, pharmacokinetics, safety, and immunogenicity of Bmab 1000 vs reference denosumab: 78-wk results from a randomized, double-blind, multicenter, parallel-arm Phase 3 trial (DEVOTE) in women with postmenopausal osteoporosis.
  • 1 Jun 2026
  • JBMR plus
Evaluation of the use of segmentation-based and deconvolution-based three-dimensional joint space width analysis of the hand and wrist.
  • 1 Jun 2026
  • JBMR plus
An osteoporotic bone model: developing and validating an ex-vivo bone demineralization protocol.
  • 1 Jun 2026
  • JBMR plus
Risk factors for atypical femur fractures with and without bisphosphonate treatment: a national nested case-control study.
  • 1 Jun 2026
  • JBMR plus

FAQs on JBMR Plus